title: Adverse effects of 2,4-dichlorophenoxyacetic acid on rat cerebellar granule cell cultures were attenuated by amphetamine.
abstract: 2,4-Dichlorophenoxyacetic acid (2,4-D), a worldwide-used herbicide, has been shown to produce a wide range of adverse effects in the health--from embryotoxicity and teratogenicity to neurotoxicity--of animals and humans. In this study, neuronal morphology and biochemical events in rat cerebellar granule cell (CGC) cultures have been analyzed to define some of the possible mechanisms involved in 2,4-D-induced cell death. For that purpose, amphetamine (AMPH) that has been shown to accelerate the recovery of several functions in animals with brain injury has been used as a pharmacologycal tool and was also investigated as a possible protecting agent. Addition of 2,4-D to CGC cultures produced a drastic decrease in cell viability, in association with an increased incidence of necrosis and apoptosis, and an increased level of reactive oxygen species, a decrease in glutathione content, and an abnormal activity of some enzymes with respect to the control group. The adverse effects of 2,4-D were partly attenuated in presence of AMPH. Some deleterious effects on several ultrastructural features of the cells, as well as the enhanced incidence of apoptosis, were partially preserved in AMPH-protected cultures as compared with those which were exposed to 2,4-D alone. The collected evidences (1) confirms the previously observed, deleterious effects of 2.4D on the same or a similar model; (2) suggests that the 2,4-D-induced apoptosis could have been mediated by or associated to an oxidative imbalance in the affected cells, and (3) shows some evidence of a protective effect of AMPH on 2,4-D-induced cell death, which could have been exerted through a reduction in the oxidative stress.
authors.affiliation: Laboratorio de Toxicología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, 2000 Rosario, Argentina. bettina.bongiovanni@gmail.com
authors.forename: B
authors.initials: B
authors.lastname: Bongiovanni
authors.forename: A
authors.initials: A
authors.lastname: Ferri
authors.forename: A
authors.initials: A
authors.lastname: Brusco
authors.forename: M
authors.initials: M
authors.lastname: Rassetto
authors.forename: L M
authors.initials: LM
authors.lastname: Lopez
authors.forename: A M
authors.initials: AM
authors.lastname: Evangelista de Duffard
authors.forename: R
authors.initials: R
authors.lastname: Duffard
mesh_terms: D015084:2,4-Dichlorophenoxyacetic Acid / Q000037:antagonists & inhibitors / Q000633:toxicity*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D003594:Cytoplasmic Granules / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D005260:Female; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D018696:Neuroprotective Agents / Q000494:pharmacology; D011247:Pregnancy; D011485:Protein Binding / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar
chemical_list: D018696:Neuroprotective Agents; D015084:2,4-Dichlorophenoxyacetic Acid; D000661:Amphetamine
references.citation: Brain Res Bull. 2003 Aug 30;61(4):365-74
references.pmid: 12909279
references.citation: Pharmacol Ther. 2003 Jul;99(1):45-53
references.pmid: 12804698
references.citation: J Lab Clin Med. 1967 Jul;70(1):158-69
references.pmid: 6066618
references.citation: Toxicol Appl Pharmacol. 2000 Sep 15;167(3):222-30
references.pmid: 10986013
references.citation: Cancer Res. 1997 May 15;57(10):1835-40
references.pmid: 9157970
references.citation: Int Rev Cytol. 2003;224:29-55
references.pmid: 12722948
references.citation: Braz J Med Biol Res. 2007 Aug;40(8):1011-24
references.pmid: 17665037
references.citation: J Cell Biol. 1963 Apr;17:208-12
references.pmid: 13986422
references.citation: Crit Rev Toxicol. 2002 Jul;32(4):233-57
references.pmid: 12184504
references.citation: J Biol Chem. 1969 Nov 25;244(22):6049-55
references.pmid: 5389100
references.citation: Brain Res. 2000 Jan 3;852(1):221-4
references.pmid: 10661517
references.citation: J Neurochem. 1992 Nov;59(5):1609-23
references.pmid: 1402908
references.citation: Prog Neurobiol. 2000 Dec;62(6):649-71
references.pmid: 10880854
references.citation: Toxicol Appl Pharmacol. 1999 Jan 15;154(2):117-25
references.pmid: 9925795
references.citation: J Biol Chem. 1952 Mar;195(1):133-40
references.pmid: 14938361
references.citation: Anal Biochem. 1977 Dec;83(2):346-56
references.pmid: 603028
references.citation: Comp Biochem Physiol C Toxicol Pharmacol. 2003 Aug;135(4):435-41
references.pmid: 12965188
references.citation: Neurotox Res. 2007 Feb;11(2):93-9
references.pmid: 17449452
references.citation: Biochem J. 1995 Apr 1;307 ( Pt 1):99-106
references.pmid: 7718000
references.citation: Crit Rev Neurobiol. 1996;10(3-4):291-316
references.pmid: 8978984
references.citation: Neurochem Res. 2002 Nov;27(11):1439-46
references.pmid: 12512947
references.citation: Exp Neurol. 2004 Sep;189(1):78-93
references.pmid: 15296838
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Neuroscience. 2006 Feb;137(3):727-35
references.pmid: 16338078
references.citation: Cell Death Differ. 1997 Aug;4(6):516
references.pmid: 16465273
references.citation: Nitric Oxide. 2001 Feb;5(1):62-71
references.pmid: 11178938
references.citation: J Exp Med. 1997 Apr 21;185(8):1481-6
references.pmid: 9126928
references.citation: Hum Immunol. 2001 Jan;62(1):64-74
references.pmid: 11165716
references.citation: Brain Res. 2006 Jun 30;1097(1):224-9
references.pmid: 16730669
references.citation: Biomed Pharmacother. 2004 Jan;58(1):39-46
references.pmid: 14739060
references.citation: Chem Biol Interact. 2001 Sep 28;137(3):229-41
references.pmid: 11566291
references.citation: Neurotoxicol Teratol. 2003 Sep-Oct;25(5):607-13
references.pmid: 12972074
references.citation: Toxicology. 1999 Aug 13;136(1):41-52
references.pmid: 10499849
references.citation: Mol Chem Neuropathol. 1997 Apr;30(3):175-85
references.pmid: 9165484
references.citation: J Neurochem. 1987 Dec;49(6):1801-9
references.pmid: 2890714
references.citation: Food Chem Toxicol. 2003 Mar;41(3):385-93
references.pmid: 12504171
references.citation: Brain Res. 1999 Apr 24;826(1):53-62
references.pmid: 10216196
references.citation: Med Hypotheses. 2008;70(3):482-7
references.pmid: 17728070
references.citation: Redox Rep. 2001;6(2):77-90
references.pmid: 11450987
references.citation: J Biol Chem. 1999 Oct 8;274(41):29075-80
references.pmid: 10506160
references.citation: Neuropharmacology. 2000 Mar 3;39(5):852-9
references.pmid: 10699450
references.citation: Eur J Pharmacol. 2007 Sep 24;571(1):25-8
references.pmid: 17618619
references.citation: Chemosphere. 2001 May-Jun;43(4-7):801-5
references.pmid: 11372868
references.citation: J Immunol. 1995 Apr 1;154(7):3194-203
references.pmid: 7897207
references.citation: Drugs Aging. 2004;21(2):67-79
references.pmid: 14960125
references.citation: Neurotoxicology. 2001 Apr;22(2):221-32
references.pmid: 11405254
references.citation: Neurosci Lett. 2005 Jun 3;380(3):214-8
references.pmid: 15862888
references.citation: Free Radic Biol Med. 1994 Sep;17(3):235-48
references.pmid: 7982629
references.citation: Cell Biol Int. 2000;24(10):705-11
references.pmid: 11023648
references.citation: Toxicol Sci. 2000 Jul;56(1):133-40
references.pmid: 10869461
references.citation: Drug Chem Toxicol. 2007;30(1):17-30
references.pmid: 17364861
references.citation: J Toxicol Clin Toxicol. 2000;38(2):111-22
references.pmid: 10778907